Dysregulation of the IGF pathway is implicated in the pathogenesis of HCC, particularly in patients with NAFLD and the metabolic syndrome, which are associated with insulin resistance, chronic hyperinsulinemia, and increased levels of bioavailable IGF-1. The gene discussed is IGF1; the disease is metabolic syndrome.